Bispecific Antibody Therapy for Multiple Myeloma: A Practical Toolkit
We believe that the expert insights presented here will help to educate healthcare professionals and optimize patient outcomes by guiding the implementation of bispecific antibody therapy into real-world practice.
Authors
- Cyrille Touzeau (ORCID: https://orcid.org/0000-0003-0275-2575)
- Edvan de Queiroz Crusoé (ORCID: https://orcid.org/0000-0002-8599-4731)
- Fernando Vieira Pericole (ORCID: https://orcid.org/0000-0003-2369-0545)
- Vania Hungria
- Cesar Rodriguez
Institutions
- Universidade Federal da Bahia (BR)
- Universidade Estadual de Campinas (UNICAMP) (BR)
- Centre Hospitalier Universitaire de Nantes (FR)
- São Germano Oncologia (BR)
- Hospital de Clínicas da Unicamp (BR)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Clinical Lymphoma Myeloma & Leukemia
- Published
- 2025-12-26
- DOI
- https://doi.org/10.1016/j.clml.2025.12.015
- Citations
- 1
- Primary Topic
- Monoclonal and Polyclonal Antibodies Research
- Type
- article
- Field-Weighted Citation Impact
- 1.36